Panel Discussion: Improving Patient Monitoring through Innovations in Liquid Biopsy Analysis

  • Discussing innovations in liquid for early cancer detection and monitoring
  • How to integrate liquid biopsy derived markers into clinical trial designs
  • How can we build successful liquid biopsy collaborations to pioneer future trial design?
  • What are the key FDA regulatory requirements for liquid biopsy assays, and how do they differ for companion diagnostics versus standalone tests?